Bupivacaine liposome gets 2019 CDT code

By DrBicuspid Staff

November 12, 2018 -- The ADA has created a new Code on Dental Procedures and Nomenclature (CDT) for Exparel, a bupivacaine liposome injectable suspension from Pacira Pharmaceuticals.

The new CDT code, D9613, will go into effect on January 1, 2019.

In addition, the U.S. Centers for Medicare and Medicaid Services (CMS) has created a billing code for Exparel. The CMS code, C9290, will also go into effect on January 1, and it will reimburse Exparel at about the average sales price, according to Pacira.


Copyright © 2018 DrBicuspid.com
 

To read this and get access to all of the exclusive content on DrBicuspid.com create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a DrBicuspid.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: